Analysis of the inflammatory response induced by substance P in the mouse pleural cavity

Peptides

Volumn 20, Issue 2, 1999, Pages 259-265

  Fröde Saleh, Tânia S ^a   Calixto, João B ^a   Medeiros, Yara S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Inflammatory mediators; Mouse pleurisy; Substance P; Tachykinin receptor antagonists

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ[8 LEUCINE 9 DEARGININE]; CROMOGLYCATE DISODIUM; DEXAMETHASONE; HISTAMINE; ICATIBANT; INDOMETACIN; KININ DERIVATIVE; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NITRIC OXIDE; OSANETANT; PROSTAGLANDIN SYNTHASE; SALBUTAMOL; SAREDUTANT; SUBSTANCE P; TERFENADINE; THEOPHYLLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; LEUKOCYTE MIGRATION INHIBITION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL;

ANIMALIA;

EID: 2942636004     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00170-3     Document Type: Article

References (27)

1. Aramori I., Morikawa N., Zenkoh J., O'donnell N., Iwami M., Kojo H., Notsu Y., Okuhara M., Ono S., Nakanishi S. Subtype and species-selectivity of a tachykinin receptor antagonist, FK 888, for cloned rat and human tachykinin receptors. Eur. J. Pharmacol. 269:1994;277-281.
2. Advenier C., Lagente V., Biochot E. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness airway inflammation and cough. Eur. Resp. J. 10:1997;1892-1906.
3. Barnes P.J., Adcock I. Antiinflammatory actions of steroids molecular mechanisms . Trends Pharmacol. Sci. 14:1993;436-441.
4. Baumgarten C.R., O'Connor A., Dokic D., Schultz K.D., Kunkel G. Substance P is generated in vivo following nasal challenge of allergic individuals with bradykinin. Clin. Exp. Allergy. 27:1997;1322-1327.
5. Belvisi M.G., Patacchini R., Barnes P.J., Maggi C.A. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission evidence for species differences . Br. J. Pharmacol. 111:1994;103-110.
6. Bertrand C.P., Geppetti C.P. Tachykinin and kinin receptor antagonists therapeutic perspectives in allergic airway disease . Trends Pharmacol. Sci. 17:1996;255-259.
7. Capaz F.R., Ruffie C., Lefort J., Manzini S., Vargaftig B.B., Pretolani M. Effect of active sensitization on the bronchopulmonary responses to tachykinins in the guinea pig Modulation by peptidase inhibitors . J. Pharmacol. Exp. Ther. 266:1993;812-819.
8. Donnerer J., Amann R. The inhibition of neurogenic inflammation. Gen. Pharmacol. 24:1993;519-529.
9. Figini M., Javdan P., Cioncolini F., Geppetti P. Involvement of tachykinins in plasma extravasation induced by bradykinin and low pH medium in the guinea pig conjuntiva. Br. J. Pharmacol. 115:1995;128-132.
10. Garland A., Jordan J.E., Ray D.W., Spaethe S.M., Alger L., Solway J. Role of eicosanoids in hyperpnea-induced airway responses in guinea pigs. J. Appl. Physiol. 75:1993;2797-2804.
11. Geppetti P., Bertrand C., Ricciardolo M.L., Nadel J.A. New aspects on the role of kinins in neurogenic inflammation. Can. J. Physiol. Pharmacol. 73:1995;843-847.
12. 1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo. Br. J. Pharmacol. 113:1994;522-526.
13. Henriques M.G., Weg V.B., Martins M.A., Silva P.M.R., Fernandes P.D., Cordeiro R.S.B., Vargaftig B.B. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse. Br. J. Pharmacol. 99:1990;164-168.
14. Iwamoto I., Tomioka H., Yoshida D. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration. J. Immunol. 151:1993;2116-2123.
15. Joos G.F., Kips J.C., Peleman R.A., Pauwels R.A. Tachykinin antagonists and the airways. Arch. Int. Pharmacodyn. Ther. 329:1995;205-220.
16. Maggi C.A. The mammalian tachykinin receptors. Gen. Pharmacol. 26:1995;911-944.
17. Martins M.A., Pasquale C.P., Silva Cordeiro P.M., Vargaftig R.S. Eosinophil accumulation in the rat pleural cavity after mast cell stimulation with compound 48/80 involves protein synthesis and is selectively suppressed by dexamethasone. Int. Arch. Allergy Appl. Immunol. 92:1990;416-424.
18. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:1993;229-308.
19. Pataccchini R., Maggi C.A. Tachykinin receptors and receptor subtypes. Arch. Int. Pharmacodyn. Ther. 329:1995;161-184.
20. Phillips T.J., Kanj L.F., Washek D., Lew R. Topical cromolyn can modify human allergic skin reactions. Allergy. 51:1996;198-199.
21. Ralevic V., Khalil Z., Helme D., Dusting G.J. Role of nitric oxide in the actions of substance P and other mediators of inflammation in rat skin microvasculature. Eur. J. Pharmacol. 284:1995;231-239.
22. Regoli D., Nantel J.A. Pharmacology of neurokinin receptors. Biopolymers. 31:1991;777-783.
23. Ricciardolo F.L., Nadel J.A., Graf P.D., Bertrand C., Yoshihara S., Geppetti P. Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea pigs. Br. J. Pharmacol. 113:1994;508-512.
24. Saleh T.S.F., Calixto J.B., Medeiros Y.S. Antiinflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. Br. J. Pharmacol. 118:1996;811-819.
25. Saleh T.S.F., Calixto J.B., Medeiros Y.S. Pro-inflammatory effects induced by bradykinin in a murine model of pleurisy. Eur. J. Pharmacol. 331:1997;43-52.
26. Shelhamer J.H., Levine S.J., Wu T., Jacoby D.B., Kaliner M.A., Rennard S.I. Airway inflammation. Ann. Int. Med. 123:1995;288-304.
27. Yano H., Wershil B.K., Arizono N., Galli S.J. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J. Clin. Invest. 84:1989;1276-1286.